9620 Federal Register / Vol. 87, No. 35 / Tuesday, February 22, 2022 / Notices 

Amount of Award: The approximate 

year 1 funding amount will be 

$3,000,000 in Federal Fiscal Year (FYY) 

2022 funds, subject to the availability of 

funds. Funding amounts for years 2–5 

will be set at continuation. 

Authority: Public Law 108–25 (the 

United States Leadership Against HIV 

AIDS, Tuberculosis and Malaria Act of 

2003). 

Period of Performance: September 30, 

2022 through September 29, 2027. 

Dated: February 15, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–03631 Filed 2–18–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–22–21HD] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled the ‘‘One Health 

Surveillance for Zoonotic SARS–CoV–2 

Events’’ to the Office of Management 

and Budget (OMB) for review and 

approval. CDC previously published a 

‘‘Proposed Data Collection Submitted 

for Public Comment and 

Recommendations’’ notice on August 

13, 2021 to obtain comments from the 

public and affected agencies. CDC 

received one comment related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

One Health Surveillance for Zoonotic 

SARS–CoV–2 Events—New—National 

Center for Emerging and Zoonotic 

Infectious Diseases (NCEZID), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

NCEZID seeks OMB approval for One 

Health Surveillance for Zoonotic SARS– 

CoV–2 Events through the use of two 

forms: One Health Case Investigation 

Form for Animals with SARS–CoV–2, 

and Zoonotic SARS–CoV–2 Event Form. 

Description of these forms and activities 

associated with this study, including 

burden to respondents can be found 

below. 

Zoonotic SARS–CoV–2 Event Form: 

Although it is now well established that 

SARS–CoV–2 is a zoonotic virus (i.e., 

can be spread between people and 

animals), little information exists on the 

prevalence or likelihood of zoonotic 

transmission events. Currently, 

reporting of zoonotic SARS–CoV–2 

transmission events is not 

systematically reported. Without this 

crucial information, however, 

interpreting data on SARS–CoV–2 

infection in animals, especially the 

overall contribution of zoonotic 

transmission to the spread of COVID– 

19, is incomplete. The information 

gathered using this surveillance 

mechanism will provide insight into the 

role of animals in SARS–CoV–2 

transmission and will also provide 

context for understanding prevalence of 

linked human and animal infections 

throughout the nation. 

Positive SARS–CoV–2 animal samples 

must be confirmed by United States 

Department of Agriculture (USDA) 

National Veterinary Services Lab 

(NVSL); however, without the proposed 

surveillance mechanism, data on linked 

human and animal transmission events 

which yield negative results would not 

be tracked at the national level. CDC 

and USDA guidance recommends statelevel health authorities, namely state 

public health veterinarians and state 

animal health officials, are involved in 

approving and coordinating animal 

SARS–CoV–2 testing. These officials are 

therefore the primary target audience for 

this surveillance form, in addition to 

tribal, local and territorial health 

authorities. The Zoonotic SARS–CoV–2 

Event form includes questions intended 

to improve our understanding of the 

number of cases state officials are asked 

to consult upon regarding SARS–CoV– 

2 testing for potential zoonotic 

transmission events, the proportion of 

those events that are tested for SARS– 

CoV–2, and corresponding relevant 

epidemiological data (epidemiological 

links to other cases of SARS–CoV–2 in 

people or animals, clinical signs, etc.), 

results, etc. This form will fill a needed 

gap over the next three years. 

In addition to the primary reason for 

the Zooonotic SARS–CoV–2 Event form, 

it will also be used to replace paperbased reporting for CDC-funded 

research. Currently, CDC’s One Health 

Office has funded surveillance and 

research at sites throughout the nation. 

This surveillance form will be used to 

report all linked human and animal 

testing for SARS–CoV–2 to CDC that is 

occurring through funded surveillance 

activities, including the status and 

circumstances for testing. This will 

relieve the requirement for less secure 

reporting such as paper-based reporting 

forms sent through email. 

More broadly, we expect this form 

may be generalized in the future to 

encapsulate surveillance for other 

zoonotic respiratory viruses. This 

surveillance form therefore offers the 

opportunity to test and iterate upon 

surveillance mechanisms prior to the 

advancement of a broader surveillance 

system. 

One Health Case Investigation Form 

for Animals with SARS–CoV–2: 

Currently, most animal samples that test 

positive for SARS–CoV–2 are confirmed 

by USDA NVSL, and are reported to the 

World Organization for Animal Health 

(OIE). However, the information 

collected is largely restricted to 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 35 / Tuesday, February 22, 2022 / Notices 9621 

information on the animal case, 

including animal species, number of 

affected animals, and clinical signs. 

Richer epidemiological data, including 

the routes that animals become exposed 

to SARS–CoV–2 and potential 

transmission events back to people, are 

needed to better understand the 

zoonotic potential of SARS–CoV–2, 

whether transmission is becoming 

sustained among animal populations, 

and the public health risks that infected 

animals may pose. Through this data 

collection tool, state and local public 

health and animal health officials will 

be able to use a standardized approach 

to collect epidemiological data while 

conducting One Health epidemiologic 

investigations over the tool’s expected 

reporting lifespan of three years. 

CDC and USDA guidance 

recommends state-level health 

authorities, namely state public health 

veterinarians and state animal health 

officials, conduct follow-up 

investigations if and when an animal is 

identified as positive for SARS–CoV–2. 

These officials, in addition to other 

state, tribal, local, and territorial (STLT) 

collaborators conducting research or 

surveillance within their jurisdiction are 

therefore an appropriate target audience 

for this surveillance form. This form 

involves voluntary reporting from STLT 

health officials conducting 

epidemiological investigations to enter 

case information and return it to CDC. 

This tool was designed by CDC staff at 

the request of STLT partners. 

These data will be used to describe 

the transmission dynamics and natural 

history of SARS–CoV–2 infection. 

Specifically, this tool will assist in 

collecting and compiling data to better 

understand the zoonotic potential of 

SARS–CoV–2 from humans or other 

sources, and the role animals infected 

with SARS–CoV–2 may play in onward 

transmission to humans or other 

animals. 

CDC requests approval for an 

estimated 9,000 annual burden hours for 

this collection. There are no costs to 

respondents other than their time to 

participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average burden per response 

(hours) 

State, tribal, local, and territorial health officials.One Health Case Investigation Form for Animals with SARS–CoV–2.50 20 1 

State, tribal, local, and territorial health officials.One Health Consultation Form ...................... 80 400 15/60 

Jeffrey M. Zirger, 

Lead,Information Collection Review 

Office,Office of Scientific Integrity,Office of 

Science,Centers for Disease Control and 

Prevention. 

[FR Doc. 2022–03708 Filed 2–18–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Single-Source 

Cooperative Agreement To Fund the 

Eastern Cape Department of Health, 

South Africa 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces the 

award of approximately $1,250,000 for 

Year 1 of funding to the Eastern Cape 

Department of Health, South Africa. The 

award will strengthen public health 

policy implementation, strengthen 

Human Resources for Health (HRH) 

management, improve supply chain 

management, and strengthen Strategic 

Information (SI) management for 

program planning in the Eastern Cape 

Province of South Africa. Funding 

amounts for years 2–5 will be set at 

continuation. 

DATES: The period for this award will be 

September 30, 2022 through September 

29, 2027. 

FOR FURTHER INFORMATION CONTACT: 

Rayna Taback-Esra, Center for Global 

Health, Centers for Disease Control and 

Prevention, P.O. Box 9536, Pretoria, 

0001, South Africa, Telephone: 800– 

232–6348, Email: wxk7@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

single-source award will fund the 

Eastern Cape Department of Health to 

strengthen public health policy 

implementation, strengthen HRH 

management, improve supply chain 

management, and strengthen strategic 

information management for program 

planning. Strengthened health systems 

will support the faster adoption of 

implementation of key policies and lead 

to a more efficient HIV/TB program in 

the Eastern Cape Province of South 

Africa. The East Cape Department of 

Health South Africa is in a unique 

position to conduct this work as it is 

responsible for the management of the 

provincial health budget and delivery of 

all provincial health services. 

Summary of the Award 

Recipient: Eastern Cape Department of 

Health, South Africa. 

Purpose of the Award: The purpose of 

this award is to support a more efficient 

HIV/TB program in the Eastern Cape 

Province through improved HRH 

management, enhanced supply chain 

management, and strengthened SI 

management. 

Amount of Award: The approximate 

year 1 funding amount will be 

$1,250,000 in Federal Fiscal Year (FFY) 

2022 funds, subject to the availability of 

funds. Funding amounts for years 2–5 

will be set at continuation. 

Authority: The program is authorized 

under Public Law 108–25 (the United 

States Leadership Against HIV AIDS, 

Tuberculosis and Malaria Act of 2003). 

Period of Performance: September 30, 

2022 through September 29, 2027. 

Dated: February 15, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–03720 Filed 2–18–22; 8:45 am] 

BILLING CODE 4163–18–P 


lotter on DSK11XQN23PROD with NOTICES1